We describe a colorimetricmethod for assay of microsomal aminopeptidase (EC 3.4.11.2) activity in serum. We use a new substrate, L-leucyl-3-carboxy-4-hydroxyanilide, p-xy- for the diagnosis ofdiseases (1-5). Among the methods for determining the activity of MAP in serum (6, 7), one of the most popular involves use of ileucyl-f3-naphthylamide as substrate (8). However, thissubstrate is not very soluble in water and one ofits derivative products, p-naphthylamine, has been classified as a carcinogenic substance (9). Another method, with iAeucyl-p-nitroanilide substrate, is simple to perform (10), but some components ofserum interfere with themeasurement ofthe enzymic product, p-nitroaniline, and the colored substance formed by the condensation ofp-nitroaniline and p-dimethylaminocinnamaldehyde is unstable to changes oftemperatore. Recently, Matsuo has synthesized iAeucyl-p-diethylaminoanilide and appliedittothe assay ofMAP activity in serum (11). However, this substrate also has several disadvantages: the enzymic hydrolysis rate ofthissubstrate is no more than that of i..-leucyl-$-naphthylamide and gives resultsforpregnant subjects that are too high (12).
and in clinical chemistry this enzyme has been determined under the term "leucine aminopeptidase." Wideiy distributed in living tissues, the activity of MAP in serum is increased in patients with hepatoma, metastatic hepatoma, carcinoma ofthehead ofthepancreas, living cirrhosis, or cholangioma. Therefore assay of MAP activity can be important for the diagnosis ofdiseases (1-5). Among the methods for determining the activity of MAP in serum (6, 7), one of the most popular involves use of ileucyl-f3-naphthylamide as substrate (8). However, thissubstrate is not very soluble in water and one ofits derivative products, p-naphthylamine, has been classified as a carcinogenic substance (9). Another method, with iAeucyl-p-nitroanilide substrate, is simple to perform (10), but some components ofserum interfere with themeasurement ofthe enzymic product, p-nitroaniline, and the colored substance formed by the condensation ofp-nitroaniline and p-dimethylaminocinnamaldehyde is unstable to changes oftemperatore. Recently, Matsuo has synthesized iAeucyl-p-diethylaminoanilide and appliedittothe assay ofMAP activity in serum (11) . However, this substrate also has several disadvantages: the enzymic hydrolysis rate ofthissubstrate is no more than that of i..-leucyl-$-naphthylamide and gives resultsforpregnant subjects that are too high (12).
In Sera were collected from 24 healthy controls, nine patients with hepatobiiary disease, and 17 samples from pregnant women.
Reagents

Chemicals.
p-Xylenol (2,5-xylenol), sodium metaperiodate, potassium hydroxide, potassium phosphate monobasic, sodium phosphate dibasic, and ileucyl-p-diethylaminoanilide were from Wako Pure Chemical Industries, Ltd., Osaka, Japan. i-Leucyl--naphthylamide was from latron Laboratories, Inc., Tokyo, Japan, and tert-butyloxycarbonyl-iAeucyl-4,6-dimethylpynmidin-2-yl thio ester was from Nitto Boseki Co., Kohriyama, Japan.
Synthesis of L-leucyl-3-carboxy4-hydroxyanilzde hydrochloride (LCHA)
. This compound can be synthesized (13-15) by allowing activated i-leucine (with its amino group protected) to react with 5-aminosalicylic acidand then removing the protective group from the i-leucyl-3-carboxy-4-hydroxyanilide, as follows: In 100 mL ofdimethylformainide, dissolve 7.7 g (50 mmol) of5-aminosalicylic acidand 14 mL (100 mmol) oftriethylamine. Assay. To a testtube (1.3 cm i.d. x 10 cm) containing 1 mL of reagent A prewarmed at 37 #{176}C for 3 to 5 mm, add 20 tL of serum and incubate at 37 #{176}C for 20 mm. Then add 3 mL of reagent B. After 5 mm, measure the absorbance of the sample at 635 nm vs a blank prepared the same way but without serum. The blue color is stable for as long as 60 mm. 
Results and Discussion
Assay Variables
Stability
of the new substrate and chromogen produced.
The newly-synthesized substrate, LCHA, was readily water soluble. We dissolved 2 minol of this substrate per liter of the phosphate buffer and stored aliquots at 4, 25, and 37 #{176}C. We checked the stability of the solution during 450 days by measuring its spontaneous hydrolysis and its usefulness in determining MAP activity (Figure 1 ). At 4 and 25 #{176}C, the solution was stable for the 450-day interval, but at 37 #{176}C it spontaneously hydrolyzed.
We examined the stability of the colored substance formed by thecondensation between p-xylenol and 5-an#{252}nosalicylic acid liberated from LCHA by MAP. The blue dye was stable for60 mm at 25#{176}C and the influence oftemperature was negligible.
We tested the effect of potential interferents and anticoagulants by adding them to a pool ofnormal human sera. The results (Table 1) At higher concentrations, there was no significant increase in hydrolysis, and thereafter the rate of reaction decreased as thesubstrate concentration was increased. So maximum MAP activity was obtained when the concentration of LCHA was 1.5-2.0 mmol/L and when the reaction pH was 7.0-7.5 (at37 #{176}C).
By use of Lineweaver-Burk plots and the MichaelisMenten equation,we calculated the apparent Michaelis constant forMAP inhuman serum with LCHA substrate to be Km = 0.29 nunol/L. Km may be taken as the substrate concentration at which the reaction velocity is half the maximum, if the amount ofproduct is negligible.
MAP activity as a function of time. As Figure 3 shows, MAP activity was linearly related to duration of incubation forat least 50 mm.
Comparison with Previous Methods
We also compared the relative activity ofMAP in normal subjects (24 samples), patientswith pancreatic carcinoma (five samples), patientswith liver cirrhosis (four samples), and pregnant subjects (17 samples). In thiswe used several (r = 0.996) for sera from normal subjects and #{149} the procedure is simple; patients with hepatobiliary disease andy = 2.065x -1.413 #{149} the rate of enzymic hydrolysis is about twice as fast as (r = 0.971) forpregnant women, that with the previous subjects; 
